Education
About Us
Working with TipRanks
Follow Us
Encompass Health (EHC)
:EHC
Earnings Data
Report Date
Apr 23, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
1.2Last Year’s EPS
1.12Same Quarter Last Year
Strong Buy
Based on 7 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 06, 2025
|% Change Since: 2.90%
|Next Earnings Date:Apr 23, 2025
Earnings Call Sentiment|Positive
The earnings call reflects a strong financial performance with significant growth in revenue, EBITDA, and Medicare Advantage discharges. However, challenges such as increased group medical costs and uncertain provider tax benefits present headwinds. The overall sentiment leans towards positive due to the robust financial metrics and strategic growth initiatives.Company Guidance
During the Encompass Health Corporation's fourth quarter 2024 earnings call, the company provided guidance for 2025, projecting net operating revenue between $5.8 billion and $5.9 billion, adjusted EBITDA ranging from $1.16 billion to $1.20 billion, and adjusted earnings per share between $4.67 and $4.96. The call highlighted several key financial metrics, including a 12.7% increase in revenue, a 13.6% rise in adjusted EBITDA, a 23.2% increase in adjusted EPS, and a significant 103.7% boost in adjusted free cash flow for Q4 2024 compared to the previous year. The company also discussed expectations for hospital net preopening and ramp-up costs, estimated at $18 to $22 million, mainly weighted towards the second half of 2025. Additionally, Encompass Health plans to continue expanding its hospital network, with several new facilities expected to open in 2025, contributing to the anticipated financial performance and strategic growth.Strong Financial Performance
Revenue increased 12.7%, adjusted EBITDA increased 13.6%, adjusted EPS increased 23.2%, and adjusted free cash flow increased 103.7%.
Significant Discharge Growth
Total discharge growth for the quarter was 7.8%, with same-store discharge growth at 5.8%.
Medicare Advantage Growth
Medicare Advantage discharge growth was up 14.7% for the quarter and 12% year-to-date, with a five-year CAGR of 11.6%.
Cash Flow and Shareholder Returns
Adjusted free cash flow increased 103.7% to $190.5 million in Q4, with plans for continued share repurchase and potential dividend adjustments.
Bed Expansion and New Hospital Developments
Seven de novos and one satellite hospital planned for 2025, with 100 additional beds, highlighting strong growth in Florida.
---
EHC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
EHC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 06, 2025 | $98.43 | $99.69 | +1.28% |
| Oct 28, 2024 | $92.76 | $99.65 | +7.43% |
| Aug 05, 2024 | $89.20 | $84.23 | -5.57% |
| Apr 24, 2024 | $82.22 | $82.15 | -0.09% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Encompass Health (EHC) report earnings?
Encompass Health (EHC) is schdueled to report earning on Apr 23, 2025, TBA Not Confirmed.
What is Encompass Health (EHC) earnings time?
Encompass Health (EHC) earnings time is at Apr 23, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is EHC EPS forecast?
EHC EPS forecast for the fiscal quarter 2025 (Q1) is 1.2.
---